Skip to main content
Erschienen in: Journal of Gastrointestinal Surgery 3/2013

01.03.2013 | 2012 SSAT Plenary Presentation

Health-Related Quality of Life in Patients with Oesophageal Cancer: Analysis at Different Steps of the Treatment Pathway

verfasst von: Marco Scarpa, Luca M. Saadeh, Alessandra Fasolo, Rita Alfieri, Matteo Cagol, Francesco Cavallin, Eleonora Pinto, Giovanni Zaninotto, Ermanno Ancona, Carlo Castoro

Erschienen in: Journal of Gastrointestinal Surgery | Ausgabe 3/2013

Einloggen, um Zugang zu erhalten

Abstract

Background

The main outcome parameters in oesophageal surgery have traditionally been morbidity and mortality, but quality of life (QL) has become an important consideration in view of the severity and persistence of postoperative symptoms. The aim of this study was to analyse QL before and after oesophagectomy for oesophageal cancer and to explore possible association with patient’s and disease characteristics.

Patients and Methods

One hundred twenty-six consecutive patients presenting with oesophageal cancer to the Oncological Surgery Unit of the Veneto Institute of Oncology between 2009 and 2011 were enrolled in this prospective study. The patients were asked to answer three QL questionnaires (the Italian versions of the QLQ-C30, the QLQ-OES18, and the IN-PATSAT32 modules developed by the European Organization for Research and Treatment of Cancer) at the time of disease diagnosis, after neoadjuvant therapy, immediately after surgery and at 1, 3, 6 and 12 months postoperatively.

Results

Global quality of life (QL2 item) seemed to improve after neoadjuvant therapy but it dropped markedly after surgery. It then rose to a value in between the one registered after neoadjuvant therapy and the one at diagnosis. Emotional function and dysphagia were associated to QL2 at diagnosis. After neoadjuvant therapy, age, oesophageal stenosis, emotional function and dysphagia were associated to good quality of life at that stage. After surgery, pain was associated to quality of life at that stage. During the early follow-up phase (1–3 months after surgery), role function and postoperative urinary complications were associated to QL2. In the long-term follow-up (6–12 months), adjuvant therapy, eating disorders and postoperative complications were associated to poor quality of life.

Conclusions

Postoperative complications are associated to long-term emotional and physical function impairment which can lead to a significantly impaired global quality of life. Postoperative pain relief plays a key role in achieving a good postoperative quality of life. Finally, HRQL after oesophagectomy seems to be a function of therapeutic efficacy rather than of the specific surgical procedure used.
Literatur
1.
Zurück zum Zitat Jemal A, Murray T, Samuels A, Ghafoor A, Ward E, Thun MJ. Cancer statistics, 2003. CA Cancer J Clin. 2003 Jan–Feb;53(1):5–26. Jemal A, Murray T, Samuels A, Ghafoor A, Ward E, Thun MJ. Cancer statistics, 2003. CA Cancer J Clin. 2003 Jan–Feb;53(1):5–26.
2.
Zurück zum Zitat Ruol A, Castoro C, Portale G, Cavallin F, Sileni VC, Cagol M, Alfieri R, Corti L, Boso C, Zaninotto G, Peracchia A, Ancona E. Trends in management and prognosis for esophageal cancer surgery: twenty-five years of experience at a single institution. Arch Surg. 2009 Mar;144(3):247–54 Ruol A, Castoro C, Portale G, Cavallin F, Sileni VC, Cagol M, Alfieri R, Corti L, Boso C, Zaninotto G, Peracchia A, Ancona E. Trends in management and prognosis for esophageal cancer surgery: twenty-five years of experience at a single institution. Arch Surg. 2009 Mar;144(3):247–54
3.
Zurück zum Zitat De Vita F, Di Martino N, Orditura M, Cosenza A, Galizia G, Del Genio A, Catalano G. Preoperative chemoradiotherapy for squamous cell carcinoma and adenocarcinoma of the esophagus: a phase II study. Chest 2002;122:1302–1308.PubMedCrossRef De Vita F, Di Martino N, Orditura M, Cosenza A, Galizia G, Del Genio A, Catalano G. Preoperative chemoradiotherapy for squamous cell carcinoma and adenocarcinoma of the esophagus: a phase II study. Chest 2002;122:1302–1308.PubMedCrossRef
4.
Zurück zum Zitat Enzinger PC, Mayer RJ. Esophageal cancer. N Engl J Med. 2003 Dec 4;349(23):2241–52. Enzinger PC, Mayer RJ. Esophageal cancer. N Engl J Med. 2003 Dec 4;349(23):2241–52.
5.
Zurück zum Zitat Wu PC, Posner MC. The role of surgery in the management of oesophageal cancer. Lancet Oncol 2003;4:481–488.PubMedCrossRef Wu PC, Posner MC. The role of surgery in the management of oesophageal cancer. Lancet Oncol 2003;4:481–488.PubMedCrossRef
6.
Zurück zum Zitat Jamieson GG, Mathew G, Ludemann R, Wayman J, Myers JC, Devitt PG. Postoperative mortality following oesophagectomy and problems in reporting its rate. Br J Surg 2004;91:943–947.PubMedCrossRef Jamieson GG, Mathew G, Ludemann R, Wayman J, Myers JC, Devitt PG. Postoperative mortality following oesophagectomy and problems in reporting its rate. Br J Surg 2004;91:943–947.PubMedCrossRef
7.
Zurück zum Zitat Viklund P, Lindblad M, Lu M, Ye W, Johansson J, Lagergren J. Risk factors for complications after esophageal cancer resection: a prospective population-based study in Sweden. Ann Surg 2006; 243(2):204–11.PubMedCrossRef Viklund P, Lindblad M, Lu M, Ye W, Johansson J, Lagergren J. Risk factors for complications after esophageal cancer resection: a prospective population-based study in Sweden. Ann Surg 2006; 243(2):204–11.PubMedCrossRef
8.
Zurück zum Zitat Gebski V, Burmeister B, Smithers BM, Foo K, Zalcberg J, Simes J; Australasian Gastro-Intestinal Trials Group. Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis. Lancet Oncol. 2007 Mar;8(3):226–34. Gebski V, Burmeister B, Smithers BM, Foo K, Zalcberg J, Simes J; Australasian Gastro-Intestinal Trials Group. Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis. Lancet Oncol. 2007 Mar;8(3):226–34.
9.
Zurück zum Zitat Greer SE, Goodney PP, Sutton JE, Birkmeyer JD. Neoadjuvant chemoradiotherapy for esophageal carcinoma: a meta-analysis. Surgery. 2005 Feb;137(2):172–7. Greer SE, Goodney PP, Sutton JE, Birkmeyer JD. Neoadjuvant chemoradiotherapy for esophageal carcinoma: a meta-analysis. Surgery. 2005 Feb;137(2):172–7.
10.
Zurück zum Zitat Zacherl J, Sendler A, Stein HJ, Ott K, Feith M, Jakesz R, Siewert JR, Fink U. Current status of neoadjuvant therapy for adenocarcinoma of the distal esophagus. World J Surg. 2003 Sep;27(9):1067–74. Zacherl J, Sendler A, Stein HJ, Ott K, Feith M, Jakesz R, Siewert JR, Fink U. Current status of neoadjuvant therapy for adenocarcinoma of the distal esophagus. World J Surg. 2003 Sep;27(9):1067–74.
11.
Zurück zum Zitat Brücher BL, Stein HJ, Zimmermann F, Werner M, Sarbia M, Busch R, Dittler HJ, Molls M, Fink U, Siewert JR. Responders benefit from neoadjuvant radiochemotherapy in esophageal squamous cell carcinoma: results of a prospective phase-II trial. Eur J Surg Oncol. 2004 Nov;30(9):963–71 Brücher BL, Stein HJ, Zimmermann F, Werner M, Sarbia M, Busch R, Dittler HJ, Molls M, Fink U, Siewert JR. Responders benefit from neoadjuvant radiochemotherapy in esophageal squamous cell carcinoma: results of a prospective phase-II trial. Eur J Surg Oncol. 2004 Nov;30(9):963–71
12.
Zurück zum Zitat McLeod RS. Quality-of-life measurement in the assessment of surgical outcome. Adv Surg. 1999;33:293–309.PubMed McLeod RS. Quality-of-life measurement in the assessment of surgical outcome. Adv Surg. 1999;33:293–309.PubMed
13.
Zurück zum Zitat Scarpa M, Valente S, Alfieri R, Cagol M, Diamantis G, Ancona E, Castoro C.Systematic review of health-related quality of life after esophagectomy for esophageal cancer. World J Gastroenterol. 2011 Nov 14;17(42):4660–74. Scarpa M, Valente S, Alfieri R, Cagol M, Diamantis G, Ancona E, Castoro C.Systematic review of health-related quality of life after esophagectomy for esophageal cancer. World J Gastroenterol. 2011 Nov 14;17(42):4660–74.
14.
Zurück zum Zitat Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004 Aug;240(2):205–13. Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004 Aug;240(2):205–13.
15.
Zurück zum Zitat Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, Filiberti A,Flechtner H, Fleishman SB, de Haes JCJM, Kaasa S, Klee MC, Osoba D, Razavi D,Rofe PB, Schraub S, Sneeuw KCA, Sullivan M, Takeda F.The European Organisation for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 1993; 85: 365–376.PubMedCrossRef Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, Filiberti A,Flechtner H, Fleishman SB, de Haes JCJM, Kaasa S, Klee MC, Osoba D, Razavi D,Rofe PB, Schraub S, Sneeuw KCA, Sullivan M, Takeda F.The European Organisation for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 1993; 85: 365–376.PubMedCrossRef
16.
Zurück zum Zitat Apolone G, Filiberti A, Cifani S, Ruggiata r, Mosconi P. Evaluation of the EoRTC QLQ C30 questionnaire: a comparison with SF36 Health Survey in a cohort of Italian long survival cancer patients. Ann Oncol 1998; 9(5):549–557 Apolone G, Filiberti A, Cifani S, Ruggiata r, Mosconi P. Evaluation of the EoRTC QLQ C30 questionnaire: a comparison with SF36 Health Survey in a cohort of Italian long survival cancer patients. Ann Oncol 1998; 9(5):549–557
17.
Zurück zum Zitat Blazeby JM, Conroy T, Hammerlid E, et al. Clinical and psychometric validation of an EORTC questionnaire module, the EORTC QLQ-OES18, to assess quality of life in patients with oesophageal cancer. Eur J Cancer 39:1384–1394, 2003. Blazeby JM, Conroy T, Hammerlid E, et al. Clinical and psychometric validation of an EORTC questionnaire module, the EORTC QLQ-OES18, to assess quality of life in patients with oesophageal cancer. Eur J Cancer 39:1384–1394, 2003.
18.
Zurück zum Zitat Bredart A, Bottomley A, Blazeby J for the EORTC QOL study group. An international prospective study of the psychometric properties of the EORTC IN-PATSAT32 in assessing cancer patient perception of the quality of care received in the hospital. Eur J Cancer 2005;41:2120–31. Bredart A, Bottomley A, Blazeby J for the EORTC QOL study group. An international prospective study of the psychometric properties of the EORTC IN-PATSAT32 in assessing cancer patient perception of the quality of care received in the hospital. Eur J Cancer 2005;41:2120–31.
19.
Zurück zum Zitat Bredart A., Coens C., Aaronson N., Chie WC., Efficace F., Conroy T., Blazeby J.M., Hammerlid E., Costantini M., Joly F., Schraub S., Sezerl O., Arraras J.I., Rodary C., Costantini A., Mehlitz M., Razavi D., Bottomley A., on behalf of the EORTC Quality of Life Group and the EORTC Quality of Life Unit Determinants of patient satisfaction in oncology settings from European and Asian countries: Preliminary results based on the EORTC IN-PATSAT32 questionnaire Eur J Cancer 43 (2007) 323–330 Bredart A., Coens C., Aaronson N., Chie WC., Efficace F., Conroy T., Blazeby J.M., Hammerlid E., Costantini M., Joly F., Schraub S., Sezerl O., Arraras J.I., Rodary C., Costantini A., Mehlitz M., Razavi D., Bottomley A., on behalf of the EORTC Quality of Life Group and the EORTC Quality of Life Unit Determinants of patient satisfaction in oncology settings from European and Asian countries: Preliminary results based on the EORTC IN-PATSAT32 questionnaire Eur J Cancer 43 (2007) 323–330
20.
Zurück zum Zitat Edge, S.B.; Byrd, D.R.; Compton, C.C.; Fritz, A.G.; Greene, F.L.; Trotti, A. (Eds.)AJCC Cancer Staging Manual 7th ed. Springer 2009 Edge, S.B.; Byrd, D.R.; Compton, C.C.; Fritz, A.G.; Greene, F.L.; Trotti, A. (Eds.)AJCC Cancer Staging Manual 7th ed. Springer 2009
21.
Zurück zum Zitat Ruol A, Portale G, Castoro C, Merigliano S, Cavallin F, Battaglia G, Michieletto S, Ancona E. Management of esophageal cancer in patients aged over 80 years. Eur J Cardiothorac Surg. 2007 Sep;32(3):445–8. Ruol A, Portale G, Castoro C, Merigliano S, Cavallin F, Battaglia G, Michieletto S, Ancona E. Management of esophageal cancer in patients aged over 80 years. Eur J Cardiothorac Surg. 2007 Sep;32(3):445–8.
22.
Zurück zum Zitat Ancona E, Ruol A, Santi S, Merigliano S, Sileni VC, Koussis H, Zaninotto G, Bonavina L, Peracchia A. Only pathologic complete response to neoadjuvant chemotherapy improves significantly the long term survival of patients with resectable esophageal squamous cell carcinoma: final report of a randomized, controlled trial of preoperative chemotherapy versus surgery alone. Cancer. 2001 Jun 1;91(11):2165–74. Ancona E, Ruol A, Santi S, Merigliano S, Sileni VC, Koussis H, Zaninotto G, Bonavina L, Peracchia A. Only pathologic complete response to neoadjuvant chemotherapy improves significantly the long term survival of patients with resectable esophageal squamous cell carcinoma: final report of a randomized, controlled trial of preoperative chemotherapy versus surgery alone. Cancer. 2001 Jun 1;91(11):2165–74.
23.
Zurück zum Zitat Brunelli C, Mosconi P, Boeri P, Gangeri L, Pizzetti P, Cerrai F, Schicchi A, Apolone G, Tamburini M. Evaluation of quality of life in patients with malignant dysphagia. Tumori. 2000 Mar-Apr;86(2):134–8. Brunelli C, Mosconi P, Boeri P, Gangeri L, Pizzetti P, Cerrai F, Schicchi A, Apolone G, Tamburini M. Evaluation of quality of life in patients with malignant dysphagia. Tumori. 2000 Mar-Apr;86(2):134–8.
24.
Zurück zum Zitat Levenstein S, Li Z, Almer S, Barbosa A, Marquis P, Moser G, Sperber A, TonerB, Drossman DA. Cross-cultural variation in disease-related concerns amongpatients with inflammatory bowel disease. Am J Gastroenterol. 2001Jun;96(6):1822–30. Levenstein S, Li Z, Almer S, Barbosa A, Marquis P, Moser G, Sperber A, TonerB, Drossman DA. Cross-cultural variation in disease-related concerns amongpatients with inflammatory bowel disease. Am J Gastroenterol. 2001Jun;96(6):1822–30.
25.
Zurück zum Zitat Barbour AP, Lagergren P, Hughes R, Alderson D, Barham CP, Blazeby JM Health-related quality of life among patients with adenocarcinoma of the gastro-oesophageal junction treated by gastrectomy or oesophagectomy. Br J Surg. 2008 Jan;95(1):80–4. Barbour AP, Lagergren P, Hughes R, Alderson D, Barham CP, Blazeby JM Health-related quality of life among patients with adenocarcinoma of the gastro-oesophageal junction treated by gastrectomy or oesophagectomy. Br J Surg. 2008 Jan;95(1):80–4.
26.
Zurück zum Zitat Egberts JH, Schniewind B, Bestmann B, Schafmayer C, Egberts F, Faendrich F, Kuechler T, Tepel J. Impact of the site of anastomosis after oncologic esophagectomy on quality of life-a prospective, longitudinal outcome study. Ann Surg Oncol. 2008 Feb;15(2):566–75. Egberts JH, Schniewind B, Bestmann B, Schafmayer C, Egberts F, Faendrich F, Kuechler T, Tepel J. Impact of the site of anastomosis after oncologic esophagectomy on quality of life-a prospective, longitudinal outcome study. Ann Surg Oncol. 2008 Feb;15(2):566–75.
27.
Zurück zum Zitat Lagergren P, Avery KN, Hughes R, Barham CP, Alderson D, Falk SJ, Blazeby JM. Health-related quality of life among patients cured by surgery for esophageal cancer. Cancer. 2007 Aug 1;110(3):686–93 Lagergren P, Avery KN, Hughes R, Barham CP, Alderson D, Falk SJ, Blazeby JM. Health-related quality of life among patients cured by surgery for esophageal cancer. Cancer. 2007 Aug 1;110(3):686–93
28.
Zurück zum Zitat Reynolds JV, McLaughlin R, Moore J, Rowley S, Ravi N, Byrne PJ. Prospective evaluation of quality of life in patients with localized oesophageal cancer treated by multimodality therapy or surgery alone. Br J Surg. 2006 Sep;93(9):1084–90. Reynolds JV, McLaughlin R, Moore J, Rowley S, Ravi N, Byrne PJ. Prospective evaluation of quality of life in patients with localized oesophageal cancer treated by multimodality therapy or surgery alone. Br J Surg. 2006 Sep;93(9):1084–90.
29.
Zurück zum Zitat Avery KN, Metcalfe C, Barham CP, Alderson D, Falk SJ, Blazeby JM. Quality of life during potentially curative treatment for locally advanced oesophageal cancer. Br J Surg. 2007 Nov;94(11):1369–76. Avery KN, Metcalfe C, Barham CP, Alderson D, Falk SJ, Blazeby JM. Quality of life during potentially curative treatment for locally advanced oesophageal cancer. Br J Surg. 2007 Nov;94(11):1369–76.
30.
Zurück zum Zitat van Meerten E, van der Gaast A, Looman CW, Tilanus HW, Muller K, Essink-Bot ML. Quality of life during neoadjuvant treatment and after surgery for resectable esophageal carcinoma. Int J Radiat Oncol Biol Phys. 2008 May 1;71(1):160–6. Epub 2007 Dec 31. van Meerten E, van der Gaast A, Looman CW, Tilanus HW, Muller K, Essink-Bot ML. Quality of life during neoadjuvant treatment and after surgery for resectable esophageal carcinoma. Int J Radiat Oncol Biol Phys. 2008 May 1;71(1):160–6. Epub 2007 Dec 31.
31.
Zurück zum Zitat Viklund P, Lindblad M, Lagergren J. Influence of surgery-related factors on quality of life after esophageal or cardia cancer resection. World J Surg. 2005 Jul;29(7):841–8. Viklund P, Lindblad M, Lagergren J. Influence of surgery-related factors on quality of life after esophageal or cardia cancer resection. World J Surg. 2005 Jul;29(7):841–8.
32.
Zurück zum Zitat Rutegård M, Lagergren J, Rouvelas I, Lindblad M, Blazeby JM, Lagergren P. Population-based study of surgical factors in relation to health-related quality of life after oesophageal cancer resection. Br J Surg. 2008 May;95(5):592–601. Rutegård M, Lagergren J, Rouvelas I, Lindblad M, Blazeby JM, Lagergren P. Population-based study of surgical factors in relation to health-related quality of life after oesophageal cancer resection. Br J Surg. 2008 May;95(5):592–601.
33.
Zurück zum Zitat Brodner G, Pogatzki E, Van Aken H, Buerkle H, Goeters C, Schulzki C, Nottberg H, Mertes N. A multimodal approach to control postoperative pathophysiology and rehabilitation in patients undergoing abdominothoracic esophagectomy. AnesthAnalg. 1998 Feb;86(2):228–34. Brodner G, Pogatzki E, Van Aken H, Buerkle H, Goeters C, Schulzki C, Nottberg H, Mertes N. A multimodal approach to control postoperative pathophysiology and rehabilitation in patients undergoing abdominothoracic esophagectomy. AnesthAnalg. 1998 Feb;86(2):228–34.
34.
Zurück zum Zitat Ali M, Winter DC, Hanly AM, O’Hagan C, Keaveny J, Broe P. Prospective, randomized, controlled trial of thoracic epidural or patient-controlled opiate analgesia on perioperative quality of life. Br J Anaesth. 2010 Mar;104(3):292–7. Ali M, Winter DC, Hanly AM, O’Hagan C, Keaveny J, Broe P. Prospective, randomized, controlled trial of thoracic epidural or patient-controlled opiate analgesia on perioperative quality of life. Br J Anaesth. 2010 Mar;104(3):292–7.
35.
Zurück zum Zitat Ariga H, Nemoto K, Miyazaki S, Yoshioka T, Ogawa Y, Sakayauchi T, Jingu K, Miyata G, Onodera K, Ichikawa H, Kamei T, Kato S, Ishioka C, Satomi S, Yamada S. Prospective comparison of surgery alone and chemoradiotherapy with selective surgery in resectable squamous cell carcinoma of the esophagus. Int J Radiat Oncol Biol Phys 2009; 75: 348–356PubMedCrossRef Ariga H, Nemoto K, Miyazaki S, Yoshioka T, Ogawa Y, Sakayauchi T, Jingu K, Miyata G, Onodera K, Ichikawa H, Kamei T, Kato S, Ishioka C, Satomi S, Yamada S. Prospective comparison of surgery alone and chemoradiotherapy with selective surgery in resectable squamous cell carcinoma of the esophagus. Int J Radiat Oncol Biol Phys 2009; 75: 348–356PubMedCrossRef
36.
Zurück zum Zitat Leibman S, Smithers BM, Gotley DC, Martin I, Thomas J Minimally invasive esophagectomy: short- and long-term outcomes. Surg Endosc. 2006 Mar;20(3):428–33. Epub 2005 Dec 28 Leibman S, Smithers BM, Gotley DC, Martin I, Thomas J Minimally invasive esophagectomy: short- and long-term outcomes. Surg Endosc. 2006 Mar;20(3):428–33. Epub 2005 Dec 28
37.
Zurück zum Zitat Wang H, Feng M, Tan L, Wang Q. Comparison of the short-term quality of life in patients with esophageal cancer after subtotal esophagectomy via video-assisted thoracoscopic or open surgery. Dis Esophagus 2010; 23: 408–414PubMedCrossRef Wang H, Feng M, Tan L, Wang Q. Comparison of the short-term quality of life in patients with esophageal cancer after subtotal esophagectomy via video-assisted thoracoscopic or open surgery. Dis Esophagus 2010; 23: 408–414PubMedCrossRef
38.
Zurück zum Zitat McLeod RS, Churchill DN, Lock AM. Quality of life of patients withulcerative colitis preoperatively and postoperatively. Gastroenterology.1991;101:1307–1313. McLeod RS, Churchill DN, Lock AM. Quality of life of patients withulcerative colitis preoperatively and postoperatively. Gastroenterology.1991;101:1307–1313.
Metadaten
Titel
Health-Related Quality of Life in Patients with Oesophageal Cancer: Analysis at Different Steps of the Treatment Pathway
verfasst von
Marco Scarpa
Luca M. Saadeh
Alessandra Fasolo
Rita Alfieri
Matteo Cagol
Francesco Cavallin
Eleonora Pinto
Giovanni Zaninotto
Ermanno Ancona
Carlo Castoro
Publikationsdatum
01.03.2013
Verlag
Springer-Verlag
Erschienen in
Journal of Gastrointestinal Surgery / Ausgabe 3/2013
Print ISSN: 1091-255X
Elektronische ISSN: 1873-4626
DOI
https://doi.org/10.1007/s11605-012-2069-1

Weitere Artikel der Ausgabe 3/2013

Journal of Gastrointestinal Surgery 3/2013 Zur Ausgabe

Wie erfolgreich ist eine Re-Ablation nach Rezidiv?

23.04.2024 Ablationstherapie Nachrichten

Nach der Katheterablation von Vorhofflimmern kommt es bei etwa einem Drittel der Patienten zu Rezidiven, meist binnen eines Jahres. Wie sich spätere Rückfälle auf die Erfolgschancen einer erneuten Ablation auswirken, haben Schweizer Kardiologen erforscht.

Hinter dieser Appendizitis steckte ein Erreger

23.04.2024 Appendizitis Nachrichten

Schmerzen im Unterbauch, aber sonst nicht viel, was auf eine Appendizitis hindeutete: Ein junger Mann hatte Glück, dass trotzdem eine Laparoskopie mit Appendektomie durchgeführt und der Wurmfortsatz histologisch untersucht wurde.

Mehr Schaden als Nutzen durch präoperatives Aussetzen von GLP-1-Agonisten?

23.04.2024 Operationsvorbereitung Nachrichten

Derzeit wird empfohlen, eine Therapie mit GLP-1-Rezeptoragonisten präoperativ zu unterbrechen. Eine neue Studie nährt jedoch Zweifel an der Notwendigkeit der Maßnahme.

Ureterstriktur: Innovative OP-Technik bewährt sich

19.04.2024 EAU 2024 Kongressbericht

Die Ureterstriktur ist eine relativ seltene Komplikation, trotzdem bedarf sie einer differenzierten Versorgung. In komplexen Fällen wird dies durch die roboterassistierte OP-Technik gewährleistet. Erste Resultate ermutigen.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.